Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2011, Article ID 573974, 13 pages
Review Article

Uveal Melanoma

1Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK
2Ocular Oncology Service, St Bartholomew's Hospital, London EC1A 7BE, UK

Received 2 March 2011; Revised 20 April 2011; Accepted 28 April 2011

Academic Editor: Paolo A. Ascierto

Copyright © 2011 Vasilios P. Papastefanou and Victoria M. L. Cohen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Uveal melanoma is the most common primary intraocular malignancy and the leading primary intraocular disease which can be fatal in adults. In this paper epidemiologic, pathogenetic, and clinical aspects of uveal melanoma are discussed. Despite the advance in local ocular treatments, there has been no change in patient survival for three decades. Development of metastases affects prognosis significantly. Current survival rates, factors predictive of metastatic potential and metastatic screening algorithms are discussed. Proposed and emerging treatments for uveal melanoma metastases are also overviewed. Current advances in genetics and cytogenetics have provided a significant insight in tumours with high metastatic potential and the molecular mechanisms that underlie their development. Biopsy of those lesions may prove to be important for prognostication and to allow further research into genetic mutations and potential new therapeutic targets in the future.